Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Diabetes Mellitus, Type 2 Clinical Trial

Official title: Optimizing Colorectal Cancer Screening Among Patients With Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches

Status Recruiting

Clinical Trial Summary

This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.

Clinical Trial Description

Aim 3 is a hybrid type 2 effectiveness-implementation pilot study in six primary care safety net clinics. This single-arm study uses a pre-post design to evaluate the targeted implementation strategies impact on: (1) preliminary effectiveness and (2) implementation (i.e., feasibility and acceptability) and a mixed-method comparative case study learning evaluation for safety-net primary care adoption and implementation. Implementation strategies that will be tested were developed through a stakeholder engaged, community-based participatory implementation planning approach. This study uses a tailored combination of implementation strategies that include but are not limited to: identification of patient and practice-level barriers, patient education matierals, patient reminders provider/clinical team education, clinical champions, and audit and feedback. The impact of this evaluation will be measure using mixed methods to assess Exploration, Preparation, Implementation factors related to how organizational and contextual variables affect adoption and implementation for targeting CRC screening among patients with diabetes in safety net clinics at 12 months post intervention. Aim 3 surveys 20 clinicians and staff from 6 clinics (n=120) and conducts key-informant interviews with 8 clinic and staff members at pre- and post-implementation (who have participated in the survey; n=96) and evaluates aggregate data for 30 patients across six clinics (n=180). ;

Related Conditions & MeSH terms

• Colorectal Cancer Screening
• Colorectal Neoplasms
• Diabetes Mellitus
• Diabetes Mellitus, Type 2

• NCT number: NCT05785780
• Study type: Interventional
• Source: Rutgers, The State University of New Jersey
• Contact: Denalee O'Malley, PhD
• Phone: 848-319-0004
• Email: omalledm@rwjms.rutgers.edu
• Status: Recruiting
• Phase: N/A
• Start date: November 1, 2022
• Completion date: September 30, 2025